Within the treatment of diabetes, insulin is considered a standard of care and can be used to treat both type 1 and type 2. There are multiple types of insulins, one of which is glargine, a long-acting basal insulin. As...
9-9-2022
Diabetes affects more than 37 million U.S. adults and is the seventh leading cause of death in the country. Of that group, approximately 7.4 million rely on insulin to manage their condition. To help address this, the Centers for Medicare...
8-23-2022
Since the beginning of the summer, health authorities have been watching the development of the monkeypox outbreak which has spread through several countries where the disease is not normally reported, such as in the United States. As of Thursday, August...
8-14-2022
National Immunization Awareness Month (NIAM) is an annual observance held in August to highlight the benefits of vaccination for people of all ages. As part of our unrelenting commitment to providing a better way in healthcare, Abarca supports the importance...
8-1-2022
Jason Borschow, Abarca’s president and CEO, was invited to be a guest on a recent episode of “The Pharmacy Benefit” a podcast from PCMA. The episode, “Competition in the PBM Marketplace,” featured a lively conversation between Jason, fellow guest Mike...
7-14-2022
Abarca’s modern, fully-integrated technology platform, Darwin, powers everything the company does–from advanced clinical services to financial management to mobile apps for members. Serge Perras recently joined the company as CIO and is focused on enhancing Darwin to deliver new services...
5-13-2022
World Mental Health Month is observed every year with the overall objective of raising awareness of mental health issues around the world and mobilizing efforts in support of mental health. The initiative provides an opportunity for all stakeholders working on...
5-1-2022
AVENTURA, FL — Abarca, a pharmacy benefit manager (PBM) that is disrupting the industry with a new approach to technology and business practices, has released the findings of an independent report about their drug cost guarantee solution, Assura. The review, conducted...
4-20-2022
This month, our CEO, Jason Borschow, was invited to speak to David Williams on the HealthBiz Podcast. In the 30 minute episode, Jason shared his journey to founding Abarca, how the company leverages modern technology in healthcare, and what it...
3-30-2022
When Paul Chan joined our team as the VP of Product, he brought nearly 15 years of experience in the PBM industry–and a passion for making healthcare work better for everyone. Now, with almost a year as an Abarcan under...
3-11-2022
